Title:
CIIP Korea - AlePDD - AI-enabled Peptide Drug Discovery
Agreement Value:
$379,800.00
Agreement Date:
Jan 1, 2023 - Jan 31, 2025
Description:
As part of the international consortium project “CIIP Korea - AlePDD - AI-enabled Peptide Drug Discovery”, this project will focus on the integration of two technology platforms enabling development of cyclic peptide-based drug candidates by a combination of the AI-driven QUEST platform of Quantum Intelligence Corporation (QIC; Korea) and the GEL-Discovery Engine of 48Hour Discovery Inc. The integration will be achieved through coordinated and iterative efforts to find and optimize cyclic peptide-based drug candidates.
Organization:
National Research Council Canada
Expected Results:
The Canadian International Innovation Program fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development.
Location:
Edmonton, Alberta, CA T6G 2M9
Reference Number:
172-2022-2023-Q4-999968
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
719831695
Recipient Type:
For-profit organization
Recipient's Legal Name:
48Hour Discovery Inc.
Federal Riding Name:
Edmonton Strathcona
Federal Riding Number:
48019
Program:
Canadian International Innovation Program
Program Purpose:
The Canadian International Innovation Program fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development.
Coverage:
The Canadian International Innovation Program supports industrial R & D partnerships and matchmaking activities between Canadian companies and foreign partners with a view to accelerating commercialization and facilitating market access.